Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Barinthus Biotherapeutics (BRNS) Other Operating Expenses (2022 - 2025)

Barinthus Biotherapeutics' Other Operating Expenses history spans 3 years, with the latest figure at $4.7 million for Q3 2025.

  • For Q3 2025, Other Operating Expenses changed N/A year-over-year to $4.7 million; the TTM value through Dec 2025 reached $4.7 million, down 61.77%, while the annual FY2025 figure was $4.7 million, 61.77% down from the prior year.
  • Other Operating Expenses reached $4.7 million in Q3 2025 per BRNS's latest filing, down from $12.2 million in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $19.4 million in Q4 2022 to a low of -$10.8 million in Q3 2022.
  • Average Other Operating Expenses over 3 years is $3.9 million, with a median of $4.7 million recorded in 2025.